Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Fumio Sakamoto.
Chemical & Pharmaceutical Bulletin | 1984
Fumio Sakamoto; Shoji Ikeda; Ryoichi Hirayama; Masaru Moriyama; Mikio Sotomura; Goro Tsukamoto
Mecillinam is a unique penicillin derivative which exhibits strong antimicrobial activities against Escherichia coli and other gram-negative bacilli.1) As it is not absorbed orally,2) its sodium salt is used parenterally and two of its esters, namely pivmecillinam3) and bacmecillinam4) are clinically used as oral prodrugs mainly for urinary tract infections. We have been developing the (5-substituted 2-oxo-1,3-dioxo1-4-yl)methyl group as a new, useful pro-moiety, and the effectiveness of the prodrugs of ampicillie and norfloxacie has been reported recently. As an extension of this prodrug study we prepared some new mecillinam (5-substituted 2-oxo-1,3-dioxol-4-yl)methyl esters and examined their oral absorbabilities. The *present paper describes the preparation and characterization of these mecillinam esters.
Journal of Medicinal Chemistry | 1993
Yoshikazu Jinbo; Masahiro Taguchi; Yoshimasa Inoue; Hirosato Kondo; Tomohiro Miyasaka; Hideki Tsujishita; Fumio Sakamoto; Goro Tsukamoto
A series of novel tetracyclic pyridone carboxylic acids replacing the 10-position oxygen atom of 9,1-(epoxymethano)-7-fluoro-8-(4-methyl-1-piperazinyl)-5-oxo-5H-thiazolo [3,2-alpha]quinoline-4-carboxylic acid by imino groups (NR; R = Me, Et, c-Pr, allyl, Ph, benzyl), a sulfur atom, or a carbonyl group was prepared and evaluated for antibacterial activity and inhibitory activity on DNA gyrase isolated from E. coli KL-16. The in vitro antibacterial potency and DNA gyrase inhibitory activity were found to be in the following order: NMe > or = O > S >> C = O. Moreover, a methyl group was the optimal alkyl substituent at the 10-position nitrogen atom for antibacterial activity and for DNA gyrase inhibitory activity. 7-Fluoro-9,1-[(N-methylimino)methano]-8- (4-methyl-1-piperazinyl)-5-oxo-5H-thiazolo[3,2-alpha]quinoline-4-carboxy lic acid (10-NCH3) showed potent in vivo antibacterial activity.
Journal of Medicinal Chemistry | 1990
Hirosato Kondo; Masahiro Taguchi; Yoshimasa Inoue; Fumio Sakamoto; Goro Tsukamoto
Journal of Medicinal Chemistry | 1988
Hirosato Kondo; Fumio Sakamoto; Kiyotaka Kawakami; Goro Tsukamoto
Journal of Organic Chemistry | 1994
Yoshikazu Jinbo; Hirosato Kondo; Masahiro Taguchi; Fumio Sakamoto; Goro Tsukamoto
Journal of Medicinal Chemistry | 1992
Masahiro Taguchi; Hirosato Kondo; Yoshimasa Inoue; Yoshihiro Kawahata; Yoshikazu Jinbo; Fumio Sakamoto; Goro Tsukamoto
Bioorganic & Medicinal Chemistry | 1997
Ryoichi Hirayama; Minoru Yamamoto; Takahiro Tsukida; Konomi Matsuo; Yuji Obata; Fumio Sakamoto; Shoji Ikeda
Journal of Medicinal Chemistry | 1994
Yoshikazu Jinbo; Hirosato Kondo; Masahiro Taguchi; Yoshimasa Inoue; Fumio Sakamoto; Goro Tsukamoto
Journal of Medicinal Chemistry | 1986
Hirosato Kondo; Fumio Sakamoto; Yasuo Kodera; Goro Tsukamoto
Journal of Medicinal Chemistry | 1989
Hirosato Kondo; Fumio Sakamoto; Toshio Uno; Yoshihiro Kawahata; Goro Tsukamoto